{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "11",
                "@timestamp": "2020-08-11T10:47:57.000057-04:00",
                "@year": "2020",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "04"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Lilly Diabetes Alliance"},
                {
                    "xocs:funding-agency-matched-string": "National Institutes of Health",
                    "xocs:funding-agency-acronym": "NIH",
                    "xocs:funding-agency": "National Institutes of Health",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "National Institute of Diabetes and Digestive and Kidney Diseases",
                    "xocs:funding-agency-acronym": "NIDDK",
                    "xocs:funding-agency": "National Institute of Diabetes and Digestive and Kidney Diseases",
                    "xocs:funding-id": "R01DK107680",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000062",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001"
                },
                {
                    "xocs:funding-agency-matched-string": "Boehringer Ingelheim",
                    "xocs:funding-agency-acronym": "BI",
                    "xocs:funding-agency": "Boehringer Ingelheim",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100001003",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "AstraZeneca",
                    "xocs:funding-agency": "AstraZeneca",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004325",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck",
                    "xocs:funding-agency": "Merck",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004334",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Janssen Pharmaceuticals",
                    "xocs:funding-agency": "Janssen Pharmaceuticals",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008897",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Intarcia Therapeutics",
                    "xocs:funding-agency": "Intarcia Therapeutics",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014130",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novo Nordisk",
                    "xocs:funding-agency": "Novo Nordisk",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004191",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2623032/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-03-16T21:01:06.842823Z",
            "xocs:funding-text": "Acknowledgments. The authors thank Khanh Horst for her excellent care of the patients throughout the study and Lorrie Albarado and Deena Murphy for their expert secretarial assistance in preparation of the manuscript. Funding. This study was funded by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases grant R01-DK-107680 to R.D. Duality of Interest. R.D. receives grant support from AstraZeneca, Merck, and Janssen, is a member of the advisory boards of AstraZeneca, Janssen Pharmaceuticals, Intarcia Therapeutics, Boehringer Ingelheim, and Novo Nordisk, and is a member of the speakers bureaus of Novo Nordisk and AstraZeneca. E.C. receives grant support from AstraZeneca and Janssen Pharmaceuticals, is a member of the advisory boards of VeroScience, the Boehringer Ingelheim and Lilly Diabetes Alliance, and Sanofi, and is a member of the speakers bureaus of AstraZeneca, Janssen Pharmaceuticals, and the Boehringer Ingelheim and Lilly Diabetes Alliance. No other potential conflicts of interest relevant to this article were reported. Author Contributions. M.A., N.L., R.M., C.A., A.M.A., H.A-J., O.L., and J.A. generated the data. C.T., R.D., and E.C. and reviewed and revised the manuscript. M.A.-G. analyzed the data and wrote the manuscript. M.A.-G. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60018573",
                            "@country": "usa",
                            "city": "San Antonio",
                            "organization": [
                                {"$": "Division of Diabetes"},
                                {"$": "University of Texas Health Science Center at San Antonio"}
                            ],
                            "affiliation-id": {
                                "@afid": "60018573",
                                "@dptid": "103953863"
                            },
                            "state": "TX",
                            "@affiliation-instance-id": "2005395532-bb205b564fb6b39a170135b53faa8cb3",
                            "ce:source-text": "Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX",
                            "@dptid": "103953863"
                        },
                        "author": [
                            {
                                "ce:given-name": "Mariam",
                                "preferred-name": {
                                    "ce:given-name": "Mariam",
                                    "ce:initials": "M.",
                                    "ce:surname": "Alatrach",
                                    "ce:indexed-name": "Alatrach M."
                                },
                                "@author-instance-id": "2005395532-9997060c0b3d381ab1e9ebbd73c8947a",
                                "@seq": "1",
                                "ce:initials": "M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Alatrach",
                                "@auid": "57193693921",
                                "ce:indexed-name": "Alatrach M."
                            },
                            {
                                "ce:given-name": "Robert",
                                "preferred-name": {
                                    "ce:given-name": "Robert",
                                    "ce:initials": "R.",
                                    "ce:surname": "Martinez",
                                    "ce:indexed-name": "Martinez R."
                                },
                                "@author-instance-id": "2005395532-44947fcd7f1e013a2bfde3e52c6b937e",
                                "@seq": "3",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Martinez",
                                "@auid": "57190491301",
                                "ce:indexed-name": "Martinez R."
                            },
                            {
                                "ce:given-name": "Christina",
                                "preferred-name": {
                                    "ce:given-name": "Christina",
                                    "ce:initials": "C.",
                                    "ce:surname": "Agyin",
                                    "ce:indexed-name": "Agyin C."
                                },
                                "@author-instance-id": "2005395532-1cc39fe0d6d4cff783a5925e43924b68",
                                "@seq": "4",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Agyin",
                                "@auid": "57193687696",
                                "ce:indexed-name": "Agyin C."
                            },
                            {
                                "ce:given-name": "Ali Muhammed",
                                "preferred-name": {
                                    "ce:given-name": "Ali Muhammed",
                                    "ce:initials": "A.M.",
                                    "ce:surname": "Ali",
                                    "ce:indexed-name": "Ali A.M."
                                },
                                "@author-instance-id": "2005395532-d346fb56b76431c3836448d2e5db4694",
                                "@seq": "5",
                                "ce:initials": "A.M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Ali",
                                "@auid": "57202285108",
                                "ce:indexed-name": "Ali A.M."
                            },
                            {
                                "ce:given-name": "Hussein",
                                "preferred-name": {
                                    "ce:given-name": "Hussein",
                                    "ce:initials": "H.",
                                    "ce:surname": "Al-Jobori",
                                    "ce:indexed-name": "Al-Jobori H."
                                },
                                "@author-instance-id": "2005395532-93444a51ef619a89babfce2a225f308e",
                                "@seq": "6",
                                "ce:initials": "H.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Al-Jobori",
                                "@auid": "57193852400",
                                "ce:indexed-name": "Al-Jobori H."
                            },
                            {
                                "ce:given-name": "Olga",
                                "preferred-name": {
                                    "ce:given-name": "Olga",
                                    "ce:initials": "O.",
                                    "ce:surname": "Lavynenko",
                                    "ce:indexed-name": "Lavynenko O."
                                },
                                "@author-instance-id": "2005395532-954383c107c97b6ce851e940bdabaeae",
                                "@seq": "7",
                                "ce:initials": "O.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Lavynenko",
                                "@auid": "57215867373",
                                "ce:indexed-name": "Lavynenko O."
                            },
                            {
                                "ce:given-name": "John",
                                "preferred-name": {
                                    "ce:given-name": "John",
                                    "ce:initials": "J.",
                                    "ce:surname": "Adams",
                                    "ce:indexed-name": "Adams J."
                                },
                                "@author-instance-id": "2005395532-ed7a22556e04dbc742138c239c9f3f85",
                                "@seq": "8",
                                "ce:initials": "J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Adams",
                                "@auid": "55470131200",
                                "ce:indexed-name": "Adams J."
                            },
                            {
                                "ce:given-name": "Curtis",
                                "preferred-name": {
                                    "ce:given-name": "Curtis",
                                    "ce:initials": "C.",
                                    "ce:surname": "Triplitt",
                                    "ce:indexed-name": "Triplitt C."
                                },
                                "@author-instance-id": "2005395532-deb4921813d6cd6ec64d7469e91b6ab6",
                                "@seq": "9",
                                "ce:initials": "C.",
                                "@date-locked": "2020-07-09T16:31:26.729",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Triplitt",
                                "@auid": "6508368069",
                                "ce:indexed-name": "Triplitt C."
                            },
                            {
                                "ce:given-name": "Ralph",
                                "preferred-name": {
                                    "ce:given-name": "Ralph",
                                    "ce:initials": "R.",
                                    "ce:surname": "DeFronzo",
                                    "ce:indexed-name": "DeFronzo R."
                                },
                                "@author-instance-id": "2005395532-0011df4e0f9cf8384b56026f602abf23",
                                "@seq": "10",
                                "ce:initials": "R.",
                                "@date-locked": "2020-07-09T16:31:26.729",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "DeFronzo",
                                "@auid": "7102080966",
                                "ce:indexed-name": "DeFronzo R."
                            },
                            {
                                "ce:given-name": "Eugenio",
                                "preferred-name": {
                                    "ce:given-name": "Eugenio",
                                    "ce:initials": "E.",
                                    "ce:surname": "Cersosimo",
                                    "ce:indexed-name": "Cersosimo E."
                                },
                                "@author-instance-id": "2005395532-2c9fb4a15a9866265fba7afdc7cb59ac",
                                "@seq": "11",
                                "ce:initials": "E.",
                                "@date-locked": "2020-07-09T16:31:26.729",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Cersosimo",
                                "@auid": "7003351777",
                                "ce:indexed-name": "Cersosimo E."
                            },
                            {
                                "ce:given-name": "Muhammad",
                                "preferred-name": {
                                    "ce:given-name": "Muhammad",
                                    "ce:initials": "M.",
                                    "ce:surname": "Abdul-Ghani",
                                    "ce:indexed-name": "Abdul-Ghani M."
                                },
                                "@author-instance-id": "2005395532-bb8fb08746f781aaaf4f684635e8ef5d",
                                "@seq": "12",
                                "ce:initials": "M.",
                                "@date-locked": "2020-07-09T16:31:26.729",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Abdul-Ghani",
                                "@auid": "8604426500",
                                "ce:indexed-name": "Abdul-Ghani M."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Endocrinology and Metabolism"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@affiliation-instance-id": "2005395532-60f45cefa0231a1edf00c970489108ee",
                            "ce:source-text": "Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, and",
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Nitchakarn",
                            "preferred-name": {
                                "ce:given-name": "Nitchakarn",
                                "ce:initials": "N.",
                                "ce:surname": "Laichuthai",
                                "ce:indexed-name": "Laichuthai N."
                            },
                            "@author-instance-id": "2005395532-f466ae14f892b43416816d596e71e523",
                            "@seq": "2",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Laichuthai",
                            "@auid": "57191472270",
                            "ce:indexed-name": "Laichuthai N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60022183"},
                                {"@afid": "60031780"}
                            ],
                            "@affiliation-instance-id": "2005395532-212f222b38288eec67740b8922e0421d",
                            "ce:source-text": "King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand"
                        },
                        "author": [{
                            "ce:given-name": "Nitchakarn",
                            "preferred-name": {
                                "ce:given-name": "Nitchakarn",
                                "ce:initials": "N.",
                                "ce:surname": "Laichuthai",
                                "ce:indexed-name": "Laichuthai N."
                            },
                            "@author-instance-id": "2005395532-f466ae14f892b43416816d596e71e523",
                            "@seq": "2",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Laichuthai",
                            "@auid": "57191472270",
                            "ce:indexed-name": "Laichuthai N."
                        }]
                    }
                ],
                "citation-title": "Evidence against an important role of plasma insulin and glucagon concentrations in the increase in EGP caused by SGLT2 inhibitors",
                "abstracts": "© 2020 by the American Diabetes Association.Sodium\u2013glucose cotransport 2 inhibitors (SGLT2i) lower plasma glucose but stimulate endogenous glucose production (EGP). The current study examined the effect of dapagliflozin on EGP while clamping plasma glucose, insulin, and glucagon concentrations at their fasting level. Thirty-eight patients with type 2 diabetes received an 8-h measurement of EGP ([3-3H]-glucose) on three occasions. After a 3-h tracer equilibration, subjects received 1) dapagliflozin 10 mg (n 5 26) or placebo (n 5 12); 2) repeat EGP measurement with the plasma glucose concentration clamped at the fasting level; and 3) repeat EGP measurement with inhibition of insulin and glucagon secretion with somatostatin infusion and replacement of basal plasma insulin and glucagon concentrations. In study 1, the change in EGP (baseline to last hour of EGP measurement) in subjects receiving dapagliflozin was 22% greater (10.66 6 0.11 mg/kg/min, P < 0.05) than in subjects receiving placebo, and it was associated with a significant increase in plasma glucagon and a decrease in the plasma insulin concentration compared with placebo. Under glucose clamp conditions (study 2), the change in plasma insulin and glucagon concentrations was comparable in subjects receiving dapagliflozin and placebo, yet the difference in EGP between dapagliflozin and placebo persisted (10.71 6 0.13 mg/kg/min, P < 0.01). Under pancreatic clamp conditions (study 3), dapagliflozin produced an initial large decrease in EGP (8% below placebo), followed by a progressive increase in EGP that was 10.6% greater than placebo during the last hour. Collectively, these results indicate that 1) the changes in plasma insulin and glucagon concentration after SGLT2i administration are secondary to the decrease in plasma glucose concentration, and 2) the dapagliflozin-induced increase in EGP cannot be explained by the increase in plasma glucagon or decrease in plasma insulin or glucose concentrations.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "@country": "usa",
                        "city": "San Antonio",
                        "organization": [
                            {"$": "Division of Diabetes"},
                            {"$": "University of Texas Health Science Center at San Antonio"}
                        ],
                        "state": "TX",
                        "ce:source-text": "Division of Diabetes, University of Texas Health Science Center at San Antonio, San Antonio, TX"
                    },
                    "person": {
                        "ce:given-name": "Ralph",
                        "ce:initials": "R.",
                        "ce:surname": "DeFronzo",
                        "ce:indexed-name": "DeFronzo R."
                    }
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "https://diabetes.diabetesjournals.org/content/69/4/681",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Diabetes",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "69",
                            "@issue": "4"
                        },
                        "pagerange": {
                            "@first": "681",
                            "@last": "688"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Diabetes",
                    "publicationdate": {
                        "month": "04",
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 April 2020"
                        },
                        "day": "01"
                    },
                    "codencode": "DIAEA",
                    "sourcetitle-abbrev": "Diabetes",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "1939327X",
                            "@type": "electronic"
                        },
                        {
                            "$": "00121797",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2020"},
                    "publisher": {
                        "publishername": "American Diabetes Association Inc.",
                        "ce:e-address": {
                            "$": "membership@diabetes.org",
                            "@type": "email"
                        }
                    },
                    "@srcid": "25487"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "CABSCLASS",
                            "classification": {
                                "classification-code": "81.3.6.3",
                                "classification-description": "CLINICAL CHEMISTRY; PHYSIOLOGY; Endocrine Pancreas; Laboratory investigation"
                            }
                        },
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "3",
                                    "classification-description": "Endocrinology"
                                },
                                {
                                    "classification-code": "30",
                                    "classification-description": "Clinical and Experimental Pharmacology"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "6",
                                    "classification-description": "Internal Medicine"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2724"},
                                {"$": "2712"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "461432-26-8",
                                    "chemical-name": "dapagliflozin"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "11140-85-5"},
                                        {"$": "62340-29-8"},
                                        {"$": "9007-92-5"}
                                    ],
                                    "chemical-name": "glucagon"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "50-99-7"},
                                        {"$": "84778-64-3"}
                                    ],
                                    "chemical-name": "glucose"
                                },
                                {
                                    "cas-registry-number": "9004-10-8",
                                    "chemical-name": "insulin"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "38916-34-6"},
                                        {"$": "51110-01-1"}
                                    ],
                                    "chemical-name": "somatostatin"
                                },
                                {
                                    "cas-registry-number": "50986-29-3",
                                    "chemical-name": "glucoside"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol"},
                                {"chemical-name": "Benzhydryl Compounds"},
                                {"chemical-name": "Blood Glucose"},
                                {"chemical-name": "Glucagon"},
                                {"chemical-name": "Glucosides"},
                                {"chemical-name": "Insulin"},
                                {"chemical-name": "Sodium-Glucose Transporter 2 Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This study was funded by National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases grant R01-DK-107680 to R.D.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "NIH",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "National Institutes of Health"
                            },
                            "grant-agency-id": "100000002"
                        },
                        {
                            "grant-id": "R01-DK-107680",
                            "grant-acronym": "NIDDK",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "National Institute of Diabetes and Digestive and Kidney Diseases"
                            },
                            "grant-agency-id": "100000062"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2020 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Data-Review",
                "dbcollection": [
                    {"$": "CABS"},
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "MOSYEA"},
                    {"$": "NURSNG"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "08",
                    "@timestamp": "BST 23:08:28",
                    "@year": "2020",
                    "@month": "04"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2005395532",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "630573152",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "2020112101",
                            "@idtype": "CABS"
                        },
                        {
                            "$": "924981438",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20200257888",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "31915153",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2020039679",
                            "@idtype": "MOSYEA"
                        },
                        {
                            "$": "2020116432",
                            "@idtype": "NURSNG"
                        },
                        {
                            "$": "20200688321",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20201003514",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20200006553180",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85082146369",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85082146369",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "630573152",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76331799",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.2337/db19-0770"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "17",
                "reference": [
                    {
                        "ref-fulltext": "DeFronzo RA, Norton L, Abdul-Ghani M. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nat Rev Nephrol 2017;13:11\u201326",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Renal, metabolic and cardiovascular considerations of SGLT2 inhibition"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85003855318",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "11",
                                    "@last": "26"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.A.",
                                    "@_fa": "true",
                                    "ce:surname": "DeFronzo",
                                    "ce:indexed-name": "DeFronzo R.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Norton",
                                    "ce:indexed-name": "Norton L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Abdul-Ghani",
                                    "ce:indexed-name": "Abdul-Ghani M."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Nephrol"
                        },
                        "ce:source-text": "DeFronzo RA, Norton L, Abdul-Ghani M. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nat Rev Nephrol 2017;13:11\u201326"
                    },
                    {
                        "ref-fulltext": "Abdul-Ghani MA, Norton L, DeFronzo RA. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus. Am J Physiol Renal Physiol 2015;309:F889\u2013F900",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84948403433",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "309"},
                                "pagerange": {
                                    "@first": "F889",
                                    "@last": "F900"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Abdul-Ghani",
                                    "ce:indexed-name": "Abdul-Ghani M.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Norton",
                                    "ce:indexed-name": "Norton L."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.A.",
                                    "@_fa": "true",
                                    "ce:surname": "DeFronzo",
                                    "ce:indexed-name": "DeFronzo R.A."
                                }
                            ]},
                            "ref-sourcetitle": "Am J Physiol Renal Physiol"
                        },
                        "ce:source-text": "Abdul-Ghani MA, Norton L, DeFronzo RA. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus. Am J Physiol Renal Physiol 2015;309:F889\u2013F900"
                    },
                    {
                        "ref-fulltext": "Merovci A, Solis-Herrera C, Daniele G, et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest 2014;124:509\u2013514",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893827104",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "124"},
                                "pagerange": {
                                    "@first": "509",
                                    "@last": "514"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Merovci",
                                        "ce:indexed-name": "Merovci A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Solis-Herrera",
                                        "ce:indexed-name": "Solis-Herrera C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Daniele",
                                        "ce:indexed-name": "Daniele G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Merovci A, Solis-Herrera C, Daniele G, et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest 2014;124:509\u2013514"
                    },
                    {
                        "ref-fulltext": "Martinez R, Al-Jobori H, Ali AM, et al. Endogenous glucose production and hormonal changes in response to canagliflozin and liraglutide combination therapy. Diabetes 2018;67:1182\u20131189",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Endogenous glucose production and hormonal changes in response to canagliflozin and liraglutide combination therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85047772231",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "67"},
                                "pagerange": {
                                    "@first": "1182",
                                    "@last": "1189"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez",
                                        "ce:indexed-name": "Martinez R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Jobori",
                                        "ce:indexed-name": "Al-Jobori H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ali",
                                        "ce:indexed-name": "Ali A.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes"
                        },
                        "ce:source-text": "Martinez R, Al-Jobori H, Ali AM, et al. Endogenous glucose production and hormonal changes in response to canagliflozin and liraglutide combination therapy. Diabetes 2018;67:1182\u20131189"
                    },
                    {
                        "ref-fulltext": "Ferrannini E, Baldi S, Frascerra S, et al. Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes 2016;65:1190\u20131195",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84964608804",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "65"},
                                "pagerange": {
                                    "@first": "1190",
                                    "@last": "1195"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrannini",
                                        "ce:indexed-name": "Ferrannini E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Baldi",
                                        "ce:indexed-name": "Baldi S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Frascerra",
                                        "ce:indexed-name": "Frascerra S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes"
                        },
                        "ce:source-text": "Ferrannini E, Baldi S, Frascerra S, et al. Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes. Diabetes 2016;65:1190\u20131195"
                    },
                    {
                        "ref-fulltext": "Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest 2014; 124:499\u2013508",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84893872877",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "124"},
                                "pagerange": {
                                    "@first": "499",
                                    "@last": "508"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrannini",
                                        "ce:indexed-name": "Ferrannini E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Muscelli",
                                        "ce:indexed-name": "Muscelli E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Frascerra",
                                        "ce:indexed-name": "Frascerra S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Invest"
                        },
                        "ce:source-text": "Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest 2014; 124:499\u2013508"
                    },
                    {
                        "ref-fulltext": "Cherrington AD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999;48:1198\u20131214",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1999"},
                            "ref-title": {"ref-titletext": "Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0033126490",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "1198",
                                    "@last": "1214"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.D.",
                                "@_fa": "true",
                                "ce:surname": "Cherrington",
                                "ce:indexed-name": "Cherrington A.D."
                            }]},
                            "ref-sourcetitle": "Diabetes"
                        },
                        "ce:source-text": "Cherrington AD. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 1999;48:1198\u20131214"
                    },
                    {
                        "ref-fulltext": "Bonner C, Kerr-Conte J, Gmyr V, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 2015;21:512\u2013517",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84937763347",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "512",
                                    "@last": "517"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Bonner",
                                        "ce:indexed-name": "Bonner C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr-Conte",
                                        "ce:indexed-name": "Kerr-Conte J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Gmyr",
                                        "ce:indexed-name": "Gmyr V."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Bonner C, Kerr-Conte J, Gmyr V, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 2015;21:512\u2013517"
                    },
                    {
                        "ref-fulltext": "Lundkvist P, Pereira MJ, Kamble PG, et al. Glucagon levels during short-term SGLT2 inhibition are largely regulated by glucose changes in patients with type 2 diabetes. J Clin Endocrinol Metab 2019;104:193\u2013201",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Glucagon levels during short-term SGLT2 inhibition are largely regulated by glucose changes in patients with type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85058565527",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "104"},
                                "pagerange": {
                                    "@first": "193",
                                    "@last": "201"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Lundkvist",
                                        "ce:indexed-name": "Lundkvist P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Pereira",
                                        "ce:indexed-name": "Pereira M.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Kamble",
                                        "ce:indexed-name": "Kamble P.G."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Endocrinol Metab"
                        },
                        "ce:source-text": "Lundkvist P, Pereira MJ, Kamble PG, et al. Glucagon levels during short-term SGLT2 inhibition are largely regulated by glucose changes in patients with type 2 diabetes. J Clin Endocrinol Metab 2019;104:193\u2013201"
                    },
                    {
                        "ref-fulltext": "Kuhre RE, Ghiasi SM, Adriaenssens AE, et al. No direct effect of SGLT2 activity on glucagon secretion. Diabetologia 2019;62:1011\u20131023",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "No direct effect of SGLT2 activity on glucagon secretion"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85064072989",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "62"},
                                "pagerange": {
                                    "@first": "1011",
                                    "@last": "1023"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Kuhre",
                                        "ce:indexed-name": "Kuhre R.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Ghiasi",
                                        "ce:indexed-name": "Ghiasi S.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Adriaenssens",
                                        "ce:indexed-name": "Adriaenssens A.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetologia"
                        },
                        "ce:source-text": "Kuhre RE, Ghiasi SM, Adriaenssens AE, et al. No direct effect of SGLT2 activity on glucagon secretion. Diabetologia 2019;62:1011\u20131023"
                    },
                    {
                        "ref-fulltext": "Ali MA, Martinez R, Al-Jobori H, et al. Combination therapy with canagliflozin plus liraglutide exerts synergistic effect on weight loss, but not on HbA1c in T2DM patients. Diabetes Care. In press",
                        "@id": "11",
                        "ref-info": {
                            "ref-title": {"ref-titletext": "Combination therapy with canagliflozin plus liraglutide exerts synergistic effect on weight loss, but not on HbA1c in T2DM patients"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85082487657",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "press",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ali",
                                        "ce:indexed-name": "Ali M.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez",
                                        "ce:indexed-name": "Martinez R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Jobori",
                                        "ce:indexed-name": "Al-Jobori H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes Care"
                        },
                        "ce:source-text": "Ali MA, Martinez R, Al-Jobori H, et al. Combination therapy with canagliflozin plus liraglutide exerts synergistic effect on weight loss, but not on HbA1c in T2DM patients. Diabetes Care. In press"
                    },
                    {
                        "ref-fulltext": "Dileepan KN, Khawaja AM, Wagle SR. Studies on the mechanism of action of somatostatin on renal gluconeogenesis: evidence for the involvement of alpha 1-adrenergic stimuli. Arch Biochem Biophys 1982;213:169\u2013176",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1982"},
                            "ref-title": {"ref-titletext": "Studies on the mechanism of action of somatostatin on renal gluconeogenesis: Evidence for the involvement of alpha 1-adrenergic stimuli"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0020059846",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "213"},
                                "pagerange": {
                                    "@first": "169",
                                    "@last": "176"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.N.",
                                    "@_fa": "true",
                                    "ce:surname": "Dileepan",
                                    "ce:indexed-name": "Dileepan K.N."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Khawaja",
                                    "ce:indexed-name": "Khawaja A.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.R.",
                                    "@_fa": "true",
                                    "ce:surname": "Wagle",
                                    "ce:indexed-name": "Wagle S.R."
                                }
                            ]},
                            "ref-sourcetitle": "Arch Biochem Biophys"
                        },
                        "ce:source-text": "Dileepan KN, Khawaja AM, Wagle SR. Studies on the mechanism of action of somatostatin on renal gluconeogenesis: evidence for the involvement of alpha 1-adrenergic stimuli. Arch Biochem Biophys 1982;213:169\u2013176"
                    },
                    {
                        "ref-fulltext": "Price BA, Jaffe BM, Zinner MJ. Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog. Gastroenterology 1985;88:80\u201385",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1985"},
                            "ref-title": {"ref-titletext": "Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0021929289",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "88"},
                                "pagerange": {
                                    "@first": "80",
                                    "@last": "85"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Price",
                                    "ce:indexed-name": "Price B.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Jaffe",
                                    "ce:indexed-name": "Jaffe B.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Zinner",
                                    "ce:indexed-name": "Zinner M.J."
                                }
                            ]},
                            "ref-sourcetitle": "Gastroenterology"
                        },
                        "ce:source-text": "Price BA, Jaffe BM, Zinner MJ. Effect of exogenous somatostatin infusion on gastrointestinal blood flow and hormones in the conscious dog. Gastroenterology 1985;88:80\u201385"
                    },
                    {
                        "ref-fulltext": "Cooper AM, Braatvedt GD, Qamar MI, et al. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci (Lond) 1991;81:169\u2013175",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1991"},
                            "ref-title": {"ref-titletext": "Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0025861221",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "81"},
                                "pagerange": {
                                    "@first": "169",
                                    "@last": "175"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Cooper",
                                        "ce:indexed-name": "Cooper A.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Braatvedt",
                                        "ce:indexed-name": "Braatvedt G.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Qamar",
                                        "ce:indexed-name": "Qamar M.I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Sci (Lond)"
                        },
                        "ce:source-text": "Cooper AM, Braatvedt GD, Qamar MI, et al. Fasting and post-prandial splanchnic blood flow is reduced by a somatostatin analogue (octreotide) in man. Clin Sci (Lond) 1991;81:169\u2013175"
                    },
                    {
                        "ref-fulltext": "Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol 2017;13:572\u2013587",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Regulation of hepatic glucose metabolism in health and disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85030998024",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "572",
                                    "@last": "587"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Petersen",
                                    "ce:indexed-name": "Petersen M.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Vatner",
                                    "ce:indexed-name": "Vatner D.F."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.I.",
                                    "@_fa": "true",
                                    "ce:surname": "Shulman",
                                    "ce:indexed-name": "Shulman G.I."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Endocrinol"
                        },
                        "ce:source-text": "Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol 2017;13:572\u2013587"
                    },
                    {
                        "ref-fulltext": "Al-Jobori H, Daniele G, Cersosimo E, et al. Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes. Diabetes 2017;66:1999\u20132006",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85021083050",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "66"},
                                "pagerange": {
                                    "@first": "1999",
                                    "@last": "2006"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Al-Jobori",
                                        "ce:indexed-name": "Al-Jobori H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Daniele",
                                        "ce:indexed-name": "Daniele G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Cersosimo",
                                        "ce:indexed-name": "Cersosimo E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Diabetes"
                        },
                        "ce:source-text": "Al-Jobori H, Daniele G, Cersosimo E, et al. Empagliflozin and kinetics of renal glucose transport in healthy individuals and individuals with type 2 diabetes. Diabetes 2017;66:1999\u20132006"
                    },
                    {
                        "ref-fulltext": "Price BA, Jaffe BM, Zinner MJ. The effect of somatostatin on central hemodynamics, renal blood flow, and renal function in dogs. Surgery 1985;97:285\u2013289",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1985"},
                            "ref-title": {"ref-titletext": "The effect of somatostatin on central hemodynamics, renal blood flow, and renal function in dogs"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0022404343",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "97"},
                                "pagerange": {
                                    "@first": "285",
                                    "@last": "289"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Price",
                                    "ce:indexed-name": "Price B.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Jaffe",
                                    "ce:indexed-name": "Jaffe B.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Zinner",
                                    "ce:indexed-name": "Zinner M.J."
                                }
                            ]},
                            "ref-sourcetitle": "Surgery"
                        },
                        "ce:source-text": "Price BA, Jaffe BM, Zinner MJ. The effect of somatostatin on central hemodynamics, renal blood flow, and renal function in dogs. Surgery 1985;97:285\u2013289"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "San Antonio",
            "@id": "60018573",
            "affilname": "University of Texas Health Science Center at San Antonio",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573",
            "affiliation-country": "United States"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85082146369",
        "dc:description": "Sodium\u2013glucose cotransport 2 inhibitors (SGLT2i) lower plasma glucose but stimulate endogenous glucose production (EGP). The current study examined the effect of dapagliflozin on EGP while clamping plasma glucose, insulin, and glucagon concentrations at their fasting level. Thirty-eight patients with type 2 diabetes received an 8-h measurement of EGP ([3-3H]-glucose) on three occasions. After a 3-h tracer equilibration, subjects received 1) dapagliflozin 10 mg (n 5 26) or placebo (n 5 12); 2) repeat EGP measurement with the plasma glucose concentration clamped at the fasting level; and 3) repeat EGP measurement with inhibition of insulin and glucagon secretion with somatostatin infusion and replacement of basal plasma insulin and glucagon concentrations. In study 1, the change in EGP (baseline to last hour of EGP measurement) in subjects receiving dapagliflozin was 22% greater (10.66 6 0.11 mg/kg/min, P < 0.05) than in subjects receiving placebo, and it was associated with a significant increase in plasma glucagon and a decrease in the plasma insulin concentration compared with placebo. Under glucose clamp conditions (study 2), the change in plasma insulin and glucagon concentrations was comparable in subjects receiving dapagliflozin and placebo, yet the difference in EGP between dapagliflozin and placebo persisted (10.71 6 0.13 mg/kg/min, P < 0.01). Under pancreatic clamp conditions (study 3), dapagliflozin produced an initial large decrease in EGP (8% below placebo), followed by a progressive increase in EGP that was 10.6% greater than placebo during the last hour. Collectively, these results indicate that 1) the changes in plasma insulin and glucagon concentration after SGLT2i administration are secondary to the decrease in plasma glucose concentration, and 2) the dapagliflozin-induced increase in EGP cannot be explained by the increase in plasma glucagon or decrease in plasma insulin or glucose concentrations.",
        "pubmed-id": "31915153",
        "prism:coverDate": "2020-04-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85082146369",
        "dc:creator": {"author": [{
            "ce:given-name": "Mariam",
            "preferred-name": {
                "ce:given-name": "Mariam",
                "ce:initials": "M.",
                "ce:surname": "Alatrach",
                "ce:indexed-name": "Alatrach M."
            },
            "@seq": "1",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Alatrach",
            "@auid": "57193693921",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193693921",
            "ce:indexed-name": "Alatrach M."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85082146369"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85082146369&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85082146369&origin=inward"
            }
        ],
        "source-id": "25487",
        "citedby-count": "18",
        "prism:volume": "69",
        "subtype": "ar",
        "dc:title": "Evidence against an important role of plasma insulin and glucagon concentrations in the increase in EGP caused by SGLT2 inhibitors",
        "openaccess": "1",
        "prism:issn": "1939327X 00121797",
        "publishercopyright": "© 2020 by the American Diabetes Association.",
        "prism:issueIdentifier": "4",
        "subtypeDescription": "Article",
        "prism:publicationName": "Diabetes",
        "prism:pageRange": "681-688",
        "prism:endingPage": "688",
        "openaccessFlag": "true",
        "prism:doi": "10.2337/db19-0770",
        "prism:startingPage": "681",
        "dc:identifier": "SCOPUS_ID:85082146369",
        "dc:publisher": "American Diabetes Association Inc.membership@diabetes.org"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Benzhydryl Compounds",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Blood Glucose",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Diabetes Mellitus, Type 2",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Glucagon",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Gluconeogenesis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Glucose Clamp Technique",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Glucosides",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Insulin",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Sodium-Glucose Transporter 2 Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Internal Medicine",
            "@code": "2724",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Endocrinology, Diabetes and Metabolism",
            "@code": "2712",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Mariam",
            "preferred-name": {
                "ce:given-name": "Mariam",
                "ce:initials": "M.",
                "ce:surname": "Alatrach",
                "ce:indexed-name": "Alatrach M."
            },
            "@seq": "1",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Alatrach",
            "@auid": "57193693921",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193693921",
            "ce:indexed-name": "Alatrach M."
        },
        {
            "ce:given-name": "Nitchakarn",
            "preferred-name": {
                "ce:given-name": "Nitchakarn",
                "ce:initials": "N.",
                "ce:surname": "Laichuthai",
                "ce:indexed-name": "Laichuthai N."
            },
            "@seq": "2",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                }
            ],
            "ce:surname": "Laichuthai",
            "@auid": "57191472270",
            "author-url": "https://api.elsevier.com/content/author/author_id/57191472270",
            "ce:indexed-name": "Laichuthai N."
        },
        {
            "ce:given-name": "Robert",
            "preferred-name": {
                "ce:given-name": "Robert",
                "ce:initials": "R.",
                "ce:surname": "Martinez",
                "ce:indexed-name": "Martinez R."
            },
            "@seq": "3",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Martinez",
            "@auid": "57190491301",
            "author-url": "https://api.elsevier.com/content/author/author_id/57190491301",
            "ce:indexed-name": "Martinez R."
        },
        {
            "ce:given-name": "Christina",
            "preferred-name": {
                "ce:given-name": "Christina",
                "ce:initials": "C.",
                "ce:surname": "Agyin",
                "ce:indexed-name": "Agyin C."
            },
            "@seq": "4",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Agyin",
            "@auid": "57193687696",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193687696",
            "ce:indexed-name": "Agyin C."
        },
        {
            "ce:given-name": "Ali Muhammed",
            "preferred-name": {
                "ce:given-name": "Ali Muhammed",
                "ce:initials": "A.M.",
                "ce:surname": "Ali",
                "ce:indexed-name": "Ali A.M."
            },
            "@seq": "5",
            "ce:initials": "A.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Ali",
            "@auid": "57202285108",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202285108",
            "ce:indexed-name": "Ali A.M."
        },
        {
            "ce:given-name": "Hussein",
            "preferred-name": {
                "ce:given-name": "Hussein",
                "ce:initials": "H.",
                "ce:surname": "Al-Jobori",
                "ce:indexed-name": "Al-Jobori H."
            },
            "@seq": "6",
            "ce:initials": "H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Al-Jobori",
            "@auid": "57193852400",
            "author-url": "https://api.elsevier.com/content/author/author_id/57193852400",
            "ce:indexed-name": "Al-Jobori H."
        },
        {
            "ce:given-name": "Olga",
            "preferred-name": {
                "ce:given-name": "Olga",
                "ce:initials": "O.",
                "ce:surname": "Lavynenko",
                "ce:indexed-name": "Lavynenko O."
            },
            "@seq": "7",
            "ce:initials": "O.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Lavynenko",
            "@auid": "57215867373",
            "author-url": "https://api.elsevier.com/content/author/author_id/57215867373",
            "ce:indexed-name": "Lavynenko O."
        },
        {
            "ce:given-name": "John",
            "preferred-name": {
                "ce:given-name": "John",
                "ce:initials": "J.",
                "ce:surname": "Adams",
                "ce:indexed-name": "Adams J."
            },
            "@seq": "8",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Adams",
            "@auid": "55470131200",
            "author-url": "https://api.elsevier.com/content/author/author_id/55470131200",
            "ce:indexed-name": "Adams J."
        },
        {
            "ce:given-name": "Curtis",
            "preferred-name": {
                "ce:given-name": "Curtis",
                "ce:initials": "C.",
                "ce:surname": "Triplitt",
                "ce:indexed-name": "Triplitt C."
            },
            "@seq": "9",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Triplitt",
            "@auid": "6508368069",
            "author-url": "https://api.elsevier.com/content/author/author_id/6508368069",
            "ce:indexed-name": "Triplitt C."
        },
        {
            "ce:given-name": "Ralph",
            "preferred-name": {
                "ce:given-name": "Ralph",
                "ce:initials": "R.",
                "ce:surname": "DeFronzo",
                "ce:indexed-name": "DeFronzo R."
            },
            "@seq": "10",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "DeFronzo",
            "@auid": "7102080966",
            "author-url": "https://api.elsevier.com/content/author/author_id/7102080966",
            "ce:indexed-name": "DeFronzo R."
        },
        {
            "ce:given-name": "Eugenio",
            "preferred-name": {
                "ce:given-name": "Eugenio",
                "ce:initials": "E.",
                "ce:surname": "Cersosimo",
                "ce:indexed-name": "Cersosimo E."
            },
            "@seq": "11",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Cersosimo",
            "@auid": "7003351777",
            "author-url": "https://api.elsevier.com/content/author/author_id/7003351777",
            "ce:indexed-name": "Cersosimo E."
        },
        {
            "ce:given-name": "Muhammad",
            "preferred-name": {
                "ce:given-name": "Muhammad",
                "ce:initials": "M.",
                "ce:surname": "Abdul-Ghani",
                "ce:indexed-name": "Abdul-Ghani M."
            },
            "@seq": "12",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018573",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018573"
            },
            "ce:surname": "Abdul-Ghani",
            "@auid": "8604426500",
            "author-url": "https://api.elsevier.com/content/author/author_id/8604426500",
            "ce:indexed-name": "Abdul-Ghani M."
        }
    ]}
}}